IOMAI CORPORATION IOMI (NASDAQ)

$ 6.56

19:10

Change: unch (unch%)
Volume: 23,344

Avg. Volume:	58952
P/E Ratio:	0
EPS (Annual):	-1.00
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	25,590
Institutional Shareholders:	21.02%

Last:	6.56
Change:	unch (unch%)
Prev. Close:	6.56
Open:	6.55
Day's Range:	6.54 - 6.57
52wk Range:	0.70 - 6.57
Market Value:	168,200
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	+266.85%
Total Return Last 3 Years:	-15.17%
Total Return Last 5 Years:	-3.97%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on IOMI

Alert me

Iomai shares surge on premium buyout offer

(NEW YORK)Shares of Iomai Corp. surged Tuesday after the biotechnology company said vaccine maker Intercell AG offered a buyout deal of $189 million, a sharp premium for the shares.READ MORE

May 13, 2008 5:25PM

Keywords: IOMI

Iomai being acquired by vaccine maker Intercell

(GAITHERSBURG, Md.)Biotechnology company Iomai Corp. said late Monday it is being bought by vaccine developer Intercell AG for about $189 million, as part of that company's effort to expand its l...READ MORE

May 13, 2008 7:56AM

Keywords: IOMI

Iomai, Merck to Test Immune-Boost Patch

(GAITHERSBURG, Md.) Iomai Corp., a vaccine research company, said Thursday it will conduct preclinical trials with Merck & Co. to review uses for its patch which stimulates the immune system. The de...READ MORE

Apr 03, 2008 8:19AM

Keywords: IOMI, MRK